Brought to you by 
Masimo in $30.4mm takeover of respiratory gas analysis firm Phasein
01 Oct 2012
Executive Summary
Masimo Corp. (noninvasive monitoring technologies) has paid $30.4mm in cash for Phasein AB, a private Swedish specialist of multi-gas measurement. Phasein’s current CEO Robert Zyzanski will stay on in his role post acquisition.
Deal Industry
- Medical Devices
-
Medical Devices
- Monitoring Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Masimo in $30.4mm takeover of respiratory gas analysis firm Phasein
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice